|
Speciality Spotlight
A
New Antimalarial
Talking
Points,
‘Even
with a dose of 62.5mg tafenoquine daily for 3 days,
no reinfection occurred during the first 7 weeks.
Tafenoquine,
a new synthetic derivative of primaquine, retains
the useful properties but has a much longer
half-life. None
of the volunteers who received doses of 125mg daily
for 3 days became infected during the next 77 days.
It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.
It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.
